Apheresis Market is anticipated to grow at a CAGR of 7.9% from 2020 to 2030.

Market Industry Reports (MIR) has published a new report titled “Apheresis Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global apheresis market accounted for over approximately US$ 1.8 billion in 2019. It is anticipated to grow at a CAGR of 7.9% from 2020 to 2030.

The growth of the apheresis market can be attributed to several factors such as the prevalence of chronic diseases and the growing number of trauma and injury cases. Moreover, the rising demand for blood components and growing concerns regarding blood safety and the increasing demand for source plasma from biopharmaceutical companies across the globe is anticipated to further contribute to the substantial growth of the global market between 2019 and 2030. Additionally, the favorable reimbursement for apheresis procedures, coupled with the increase in the number of complex surgical procedures, is anticipated to further promote the growth of the apheresis market during the forecast period.

 
The adoption of apheresis is increasing across key countries majorly due to the growth in the targeted patient population, suffering from cardiovascular diseases, neurovascular disorders and cancer has played a vital role in contributing to the growth of the global apheresis industry. According to the World Health Organization, cancer is one of the leading cause of death across the world and was responsible for more than 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Moreover, an increasing number of apheresis assisted clinical research studies in several countries, namely India, China and other developing countries have emerged as essential contributors to the global apheresis market. These factors are leading to an upsurge in the apheresis market.

Many players operating in the apheresis market are following a ‘New Product Launch Strategy’ for the development and technological advancement of the product. The strategy has helped companies to develop and accelerate underdeveloped products, gain regulatory approval for the product in different geographies. For instance, in July 2019, Baxter International Inc. (US) launched the PrisMax system in the US. Additionally, In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.

Browse key industry insights spread across 180 pages with market data tables & figures & charts from the report, Apheresis Market by Product (Devices and Disposables), Technology (Centrifugation and Membrane Separation), Procedure (Therapeutic Apheresis (Therapeutic Apheresis Disposables (Blood Disorders, Autoimmune Disorders, Metabolic Disorders, and Neurological Disorders), Therapeutic Apheresis Devices, and Automated Blood Collection)), Application (Photopheresis, Leukapheresis, Plasmapheresis, and Plateletpheresis) and End User (Hospitals and Blood Centers) - Global Analysis & Forecast 2020-2030 in detail along with the table of contents:https://www.marketindustryreports.com/apheresis-market/332

However, due to lack of awareness fewer blood donations take place using apheresis, the high cost of apheresis devices, and the stringent government regulations regarding donor recruitment criteria is expected to hamper the growth of the target market.

However, due to lack of awareness fewer blood donations take place using apheresis, the high cost of apheresis devices, and the stringent government regulations regarding donor recruitment criteria is expected to hamper the growth of the target market.

The Asia Pacific apheresis market is estimated to grow at the highest CAGR during the forecast period. Increasing population, rising disposable income, continuously growing economy, and increasing awareness regarding apheresis are expected to propel the apheresis market growth in the region. Countries in the APAC, such as China, India, and Japan, are anticipated to provide significant growth opportunities for the global apheresis market due to a large number of geriatric populations susceptible to various diseases.

Some of the prominent players in the apheresis market include Terumo Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation, Baxter, B. Braun Melsungen AG, Asahi Kasei Corporation, Cerus Corporation, Kaneka Corporation, Nikkiso Co., Ltd., Sumitomo Bakelite Co., Ltd., among others.

About Us

Market Industry Reports is a global leader in market measurement and advisory services. It is a 100% subsidiary of ExlTech. The firm has always been at the forefront of innovations to address worldwide industry trends and opportunities. We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates consumer study in more than 100 countries, providing a tactical approach to drive sustained business growth. We continue to pioneer state-of-the-art approach in research & analysis that will help you to overcome complexities and stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence, we unfold contingencies for our clients in the evolving world of technology, mega-trends, and industry convergence. We inspire our clients to empower and shape their businesses and to build world-class products.

Contact Us

sales@marketindustryreports.com